Call Options Transactions Made in Q4 2023 in Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP) during Q4 2023. The information is specifically focused on institutions that hold call options of CRISPR Therapeutics AG.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
529K+ 137.36% |
$20.4M - $38.2M
|
914K
$37M
|
|
|
Feb 14, 2024
Q4 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
483K+ 496.81% |
$18.7M - $34.9M
|
581K
$23.5M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
309K+ 79.18% |
$11.9M - $22.3M
|
700K
$28.4M
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
CALL |
130K+ 16262.5% |
$5.02M - $9.39M
|
131K
$5.31M
|
|
|
Feb 14, 2024
Q4 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
BUY
|
CALL |
68.4K+ 73.95% |
$2.64M - $4.94M
|
161K
$6.52M
|
|
|
Feb 14, 2024
Q4 2023
|
Lmr Partners LLP
London, X0 |
BUY
|
CALL |
60KNew |
$2.32M - $4.33M
|
60K
$2.43M
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
CALL |
55.2K+ 293.72% |
$2.13M - $3.99M
|
74K
$3M
|
|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
BUY
|
CALL |
52KNew |
$2.01M - $3.75M
|
52K
$2.11M
|
|
|
Feb 14, 2024
Q4 2023
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
CALL |
36.3K+ 52.76% |
$1.4M - $2.62M
|
105K
$4.26M
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
CALL |
27K+ 109.76% |
$1.04M - $1.95M
|
51.6K
$2.09M
|
|
|
Feb 13, 2024
Q4 2023
|
Jefferies Financial Group Inc.
New York, NY |
BUY
|
CALL |
25KNew |
$965K - $1.8M
|
25K
$1.01M
|
|
|
Feb 14, 2024
Q4 2023
|
Capital Fund Management S.A.
Paris, I0 |
BUY
|
CALL |
21.2KNew |
$819K - $1.53M
|
21.2K
$859K
|
|
|
Feb 14, 2024
Q4 2023
|
Paul Tudor Jones
Tudor Investment Corp Et Al | Stamford, Ct
|
BUY
|
CALL |
20.9KNew |
$807K - $1.51M
|
20.9K
$847K
|
|
|
Feb 14, 2024
Q4 2023
|
Ubs Oconnor LLC
Chicago, IL |
BUY
|
CALL |
15KNew |
$579K - $1.08M
|
15K
$608K
|
|
|
Feb 14, 2024
Q4 2023
|
Squarepoint Ops LLC
New York, NY |
BUY
|
CALL |
9.1K+ 91.0% |
$351K - $657K
|
19.1K
$774K
|
|
|
Feb 13, 2024
Q4 2023
|
Peak6 Investments LLC
Chicago, IL |
BUY
|
CALL |
8.7K+ 63.04% |
$336K - $628K
|
22.5K
$912K
|
|
|
Feb 14, 2024
Q4 2023
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
7.6K+ 15.67% |
$294K - $549K
|
56.1K
$2.27M
|
|
|
Feb 14, 2024
Q4 2023
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
3.86K+ 9900.0% |
$149K - $279K
|
3.9K
$158K
|
|
|
Feb 14, 2024
Q4 2023
|
Prelude Capital Management, LLC
New York, NY |
BUY
|
CALL |
3.5KNew |
$135K - $253K
|
3.5K
$142K
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
CALL |
3.4K+ 16.67% |
$131K - $245K
|
23.8K
$965K
|
|
|
Jan 18, 2024
Q4 2023
|
Brave Asset Management Inc
|
BUY
|
CALL |
3.3K+ 165.0% |
$127K - $238K
|
5.3K
$215K
|
|
|
Jan 30, 2024
Q4 2023
|
Prosperity Wealth Management, Inc.
San Ramon, CA |
BUY
|
CALL |
1.5KNew |
$57.9K - $108K
|
1.5K
$60.8K
|
|
|
Feb 14, 2024
Q4 2023
|
Moors & Cabot, Inc.
Boston, MA |
BUY
|
CALL |
1.2KNew |
$46.3K - $86.6K
|
1.2K
$48.6K
|
|
|
Feb 12, 2024
Q4 2023
|
Draper Asset Management, LLC
Smithtown, NY |
BUY
|
CALL |
1K+ 58.82% |
$38.6K - $72.2K
|
2.7K
$109K
|
|
|
Feb 14, 2024
Q4 2023
|
Parallax Volatility Advisers, L.P.
San Francisco, CA |
SELL
|
CALL |
-300- 5.26% |
$11.6K - $21.7K
|
5.4K
$219K
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Trading LLC
Plymouth, MN |
SELL
|
CALL |
-3.7K- 3.19% |
$143K - $267K
|
112K
$4.56M
|
|
|
Feb 14, 2024
Q4 2023
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
CALL |
-4.9K- 50.0% |
$189K - $354K
|
4.9K
$199K
|